After Treatment Post-treatment care typically includes hydration, sun protection, and maintaining a healthy diet rich in antioxidants
The culmination of all of these studies come to light with the finding of several (some reported and many from our group still publication pending) Larons Syndrome (congenital IGF-1 deficiency or GH insensitivity) never treated patients who underwent progression to MetS and ultimately to T2D together with diabetic retinopathy when they reached their late 30 s, [250, 251]
IGF-1 treatment: future and limitations The FDA approved the use of rhIGF-1 (Mecasermin, Increlex) for treatment of severe primary IGF-1 deficiency in 2003
The peptide has not been approved by major regulatory bodies like the FDA, and long-term safety data is limited
Powered by Glutathione, Niacinamide & Hyaluronic Acid for brighter, smoother, deeply hydrated skin